Pressure Biosciences Inc Asset Turnover Ratio (PBIO), as of second quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Pressure Biosciences Inc   (PBIO)
 

Pressure Biosciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Pressure Biosciences Inc 's asset turnover ratio, the ratio that measures the ability of Pressure Biosciences Inc 's assets to generate revenue, sequentially decreased to 0.36 in the second quarter (Jun 30 2024), which does not come as a surprise, as the Pressure Biosciences Inc continue to experience difficult business climate.

Within sector only one company achieved higher asset turnover ratio in the second quarter 2024. While Asset turnover ratio total ranking has improved so far during the II Quarter 2024, to 1030, from total ranking in the first quarter 2024 at 1219.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PBIO Asset Turnover Ratio (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Asset Change 301.59 % 208.79 % -45.92 % -18.9 % -39.22 %
Y / Y Revenue Change -17.59 % -52.84 % -48.56 % 186.74 % 2.74 %
Asset Turnover Ratio (TTM) 0.36 0.54 1.14 1.17 0.97
PBIO's Total Ranking # 1030 # 1219 # 1216 # 1402 #
Seq. Asset Change -9.87 % 628.56 % -53.68 % 32.04 % -30.7 %
Seq. Revenue Change 20.77 % 11.82 % -24.37 % -19.3 % -30.89 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 2
Healthcare Sector # 99
Overall Market # 1030

Asset Turnover Ratio Statistics
High Average Low
11.15 5.47 2.4
(Jun 30 2024)   (Dec 31 2020)




PBIO Company Profile • Back to PBIO Efficiency Comparisons • Compare PBIO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2024 Assets at quarter ending Jun 30 2024
Intra cellular Therapies Inc   0.64 $ 564.526  Millions$ 878.375  Millions
Alimera Sciences Inc  0.64 $ 98.085  Millions$ 152.645  Millions
Aquestive Therapeutics Inc   0.64 $ 58.360  Millions$ 90.998  Millions
Align Technology inc   0.64 $ 3,941.551  Millions$ 6,179.127  Millions
Waters Corporation  0.64 $ 2,876.534  Millions$ 4,520.511  Millions
Aytu Biopharma Inc  0.63 $ 80.586  Millions$ 127.774  Millions
Teladoc Health Inc   0.63 $ 2,609.340  Millions$ 4,141.184  Millions
Caredx Inc   0.63 $ 297.084  Millions$ 471.797  Millions
Star Equity Holdings Inc   0.63 $ 47.147  Millions$ 75.068  Millions
Karyopharm Therapeutics Inc   0.63 $ 145.668  Millions$ 232.208  Millions
Castle Biosciences Inc   0.63 $ 287.589  Millions$ 458.794  Millions
Zoetis Inc   0.63 $ 8,915.000  Millions$ 14,226.250  Millions
Emergent Biosolutions Inc   0.63 $ 1,101.400  Millions$ 1,758.350  Millions
Biodesix Inc   0.63 $ 60.902  Millions$ 97.231  Millions
Cytomx Therapeutics Inc   0.62 $ 119.569  Millions$ 191.716  Millions
Atara Biotherapeutics Inc   0.62 $ 99.117  Millions$ 159.212  Millions
Edwards Lifesciences Corporation  0.62 $ 5,997.400  Millions$ 9,642.400  Millions
U S Physical Therapy Inc  0.62 $ 627.673  Millions$ 1,011.954  Millions
Incyte Corporation  0.62 $ 3,857.014  Millions$ 6,241.939  Millions
Allurion Technologies Inc   0.62 $ 46.062  Millions$ 74.735  Millions
3m Company  0.62 $ 30,583.000  Millions$ 49,705.250  Millions
Cervomed Inc   0.61 $ 12.781  Millions$ 20.800  Millions
Haemonetics Corporation  0.61 $ 1,333.207  Millions$ 2,170.667  Millions
Inotiv Inc   0.61 $ 501.062  Millions$ 820.501  Millions
Vericel Corporation  0.61 $ 214.520  Millions$ 351.321  Millions
Heron Therapeutics Inc   0.61 $ 135.294  Millions$ 221.932  Millions
Venus Concept Inc   0.61 $ 54.236  Millions$ 89.350  Millions
Guardion Health Sciences Inc   0.61 $ 7.648  Millions$ 12.625  Millions
Regen Biopharma Inc   0.60 $ 0.154  Millions$ 0.255  Millions
Alnylam Pharmaceuticals Inc   0.60 $ 2,344.406  Millions$ 3,875.743  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.